Madrigal Pharmaceuticals
(NASDAQ:MDGL)
Madrigal Pharmaceuticals, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Madrigal Pharmaceuticals, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$73.34
3.13[4.46%]
At close: Aug 12
$73.34
After Hours: 4:00PM EDT
Day High/Low70.21 - 74.27
52 Week High/Low52.33 - 105.93
Open / Close70.21 / 73.34
Float / Outstanding13.9M / 17.1M
Vol / Avg.183.8K / 178.3K
Mkt Cap1.3B
P/E-
50d Avg. Price71.19
Div / Yield-
Payout Ratio-
EPS-4.14
Total Float13.9M

Madrigal Pharmaceuticals (NASDAQ:MDGL), Quotes and News Summary

Madrigal Pharmaceuticals (NASDAQ: MDGL)

Day High/Low70.21 - 74.27
52 Week High/Low52.33 - 105.93
Open / Close70.21 / 73.34
Float / Outstanding13.9M / 17.1M
Vol / Avg.183.8K / 178.3K
Mkt Cap1.3B
P/E-
50d Avg. Price71.19
Div / Yield-
Payout Ratio-
EPS-4.14
Total Float13.9M
Sector: Health Care.Industry: Biotechnology
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Madrigal Pharmaceuticals Questions & Answers

Q
How do I buy Madrigal Pharmaceuticals (MDGL) stock?
A

You can purchase shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Madrigal Pharmaceuticals's (MDGL) competitors?
Q
What is the target price for Madrigal Pharmaceuticals (MDGL) stock?
A

The latest price target for Madrigal Pharmaceuticals (NASDAQ: MDGL) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting MDGL to fall to within 12 months (a possible -94.55% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Madrigal Pharmaceuticals (MDGL)?
A

The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $73.34 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Madrigal Pharmaceuticals (MDGL) pay a dividend?
A

The next Madrigal Pharmaceuticals (MDGL) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?
A

Madrigal Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Madrigal Pharmaceuticals (MDGL) going to split?
A

There is no upcoming split for Madrigal Pharmaceuticals.

Q
What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?
A

Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.